Randomized Placebo-Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone Alone in Patients With Hormone Refractory Metastatic Prostate Cancer and Pain.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Clodronic acid (Primary) ; Mitoxantrone; Prednisone
- Indications Cancer pain; Prostate cancer
- Focus Therapeutic Use
- 03 Apr 2020 Biomarkers information updated
- 16 Mar 2010 Actual end date (1 Feb 2009) added as reported by ClnicalTrials.gov record.
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.